Sector dividends Caplin Point Laboratories Limited NSE India S.E.
Stocks
CAPLIPOINT
INE475E01026
Pharmaceuticals
|
Market Closed -
NSE India S.E.
04:35:07 18/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,529.70 INR | +0.31% |
|
-3.80% | +37.63% |
| 15/08 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 12/08 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.91% | 1.06% | 34.73x | 4.87x | 6.51x | 22.55x | 27.28x | 4.72TCr | ||
| 1.37% | 1.46% | 18.54x | 1.93x | 2.19x | 9.99x | 12.87x | 3.96TCr | ||
| 0.91% | 1.03% | 27.87x | 3.08x | 3.39x | 17.56x | 22.52x | 1.21TCr | ||
| 0.6% | 0.63% | 27.13x | 3.74x | 3.88x | 16.07x | 22.5x | 1.18TCr | ||
| 3.85% | 3.94% | 18.73x | 3.25x | 3.33x | 11.58x | 13.79x | 911.85Cr | ||
| 4.42% | 5.14% | 9.11x | 1.57x | 2.11x | 5.48x | 6.75x | 756.88Cr | ||
| 3.25% | 3.22% | 15.69x | 1.29x | 2.04x | 6.63x | 9.53x | 710.27Cr | ||
| 0.16% | 0.17% | 28.33x | 5.2x | 3.7x | 17.19x | 20.73x | 687.4Cr | ||
| 0.9% | 1.03% | 37.01x | 8.57x | 7.24x | 26.4x | 29.15x | 485.85Cr | ||
| 3.33% | 3.83% | 15.97x | 2.61x | 2.58x | 12.03x | 11.66x | 404.94Cr | ||
| 1.87% | 1.77% | 14.42x | 0.7x | 2.02x | 8.64x | 10.92x | 389.87Cr | ||
| 2.65% | 2.72% | 14.94x | 3.01x | 3.48x | 13x | 14.36x | 297.25Cr | ||
| 3.2% | 3.56% | 18.8x | 5.04x | 5.86x | 16.65x | 18.02x | 260.84Cr | ||
| Average | 2.11% | 2.27% | 21.64x | 3.45x | 3.72x | 14.14x | 16.93x | 1.23TCr | |
| Weighted average by Cap. | 1.56% | 1.7% | 24.86x | 3.45x | 4.05x | 15.44x | 19.05x |
Select your edition
All financial news and data tailored to specific country editions
















